Nour Alhusein

Nour Alhusein

Auto-generated profile, based on publicly available information

Nour Alhusein

NIHR Bristol Biomedical Research Centre, University Hospitals Bristol and Weston NHS Foundation Trust and University of Bristol, Bristol, UK

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 June 2021 in Antibiotics
Verified
Journal Article
Open access
PDF file
WCWenjuan CONG
Wenjuan CONG
APAk Narayan Poudel
Ak Narayan Poudel
NANour Alhusein
Nour Alhusein
HWHexing Wang
Hexing Wang
GYGuiqing Yao
Guiqing Yao
HLhelen lambert
helen lambert
This scoping review provides new evidence on the prevalence and patterns of global antimicrobial use in the treatment of COVID-19 patients; identifies the most commonly used antibiotics and clinical scenarios associated with antibiotic prescribing in the first phase of the pandemic; and explores the impact of documented antibiotic prescribing on treatment outcomes in COVID-19 patients. The review complies with PRISMA guidelines for Scoping Reviews and the protocol is registered with the Open Science Framework. In the first six months of the pandemic, there was a similar mean antibiotic prescribing rate between patients with severe or critical illness (75.4%) and patients with mild or moderate illness (75.1%). The proportion of patients prescribed antibiotics without clinical justification was 51.5% vs. 41.9% for patients with mild or moderate illness and those with severe or critical illness. Comparison of patients who were provided antibiotics with a clinical justification with those who were given antibiotics without clinical justification showed lower mortality rates (9.5% vs. 13.1%), higher discharge rates (80.9% vs. 69.3%), and shorter length of hospital stay (9.3 days vs. 12.2 days). In the first 6 months of the pandemic, antibiotics were prescribed for COVID-19 patients regardless of severity of illness. A large proportion of antibiotic prescribing for mild and moderate COVID-19 patients did not have clinical evidence of a bacterial co-infection. Antibiotics may not be beneficial to COVID-19 patients without clinical evidence of a bacterial co-infection.

23 July 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
WCWenjuan CONG
Wenjuan CONG
BSBeth Stuart
Beth Stuart
NANour Aihusein
Nour Aihusein
BLBinjuan Liu
Binjuan Liu
YTYunyi Tang
Yunyi Tang
HLhelen lambert
helen lambert
This scoping review aimed to explore the prevalence and patterns of global antibiotic use and bacterial infection in COVID-19 patients from studies published between June 2020 and March 2021. This review was reported in line with the Preferred Reporting of Systematic Reviews and Meta-Analyses (PRISMA) extension for Scoping Reviews, and the protocol is registered with the Open Science Framework. Compared with our previously-published review of the period (December 2019–June 2020), the antibiotic prescribing rate for COVID-19 patients (June 2020–March 2021) was found to have declined overall (82.3% vs. 39.7%), for mild and moderate patients (75.1% vs. 15.5%), and for severe and critical patients (75.3% vs. 48.3%). The seven most frequently prescribed antibiotics in COVID-19 patients were all on the “Watch” list of the WHO AWaRe antibiotics classification. The overall reported bacterial infection rate in COVID-19 patients was 10.5%, and the most frequently reported resistant pathogen in COVID-19 patients was Staphylococcus aureus, followed by Pseudomonas aeruginosa, Escherichia coli, and Klebsiella pneumoniae. There is an urgent need to establish comprehensive and consistent guidelines to assist clinicians in selecting appropriate antibiotics for COVID-19 patients when needed. The resistance data on the most frequently used antibiotics for COVID-19 patients for certain resistant pathogens should be closely monitored.

2 July 2019 in International Journal of Pharmacy Practice
Verified
Journal Article
Open access
NANour Alhusein
Nour Alhusein
MWMargaret C Watson
Margaret C Watson
Background: Quality indicators are a commonly used improvement tool in health care. There is growing interest and activity in the use of quality indicators to improve community pharmacy practice. Objectives: To conduct a scoping review of the use of quality indicators for community pharmacy practice, including their methods of development and evaluation. Methods: Electronic databases (EMBASE and PubMed) were searched to identify papers published between January 2008 and April 2018. No limits were applied for language of publication or country of origin. Studies were included if they reported empirical data regarding the development or evaluation of quality indicators. All study designs were eligible for inclusion. Duplicate independent screening was undertaken of the search results. Data extraction was performed by one reviewer. Results: Of the 988 records identified from the database search, 15 articles were included. The studies were conducted in 12 countries from six continents. Eleven studies described the development of quality indicators, eight of which included the evaluation of the psychometric properties of the indicators developed. Four studies examined the impact of quality indicators on practice all of which reported improvements in some aspects of quality, mainly with structure indicators rather than those relating to process and outcome. Conclusions: Whilst there is a growing emphasis on promoting improvement in community pharmacy services, evidence is lacking of the effect of indicators on improving quality. Measurable process and outcome indicators are needed. The future development of quality indicators would also benefit from a multi-stakeholder approach.

8 January 2024 in Global Public Health
Verified
Journal Article
Open access
NANour Alhusein
Nour Alhusein
NCNutcha Charoenboon
Nutcha Charoenboon
KWKantima Wichuwaranan
Kantima Wichuwaranan
KPKornrawan Poonsawad
Kornrawan Poonsawad
VMVarapon Montrivade
Varapon Montrivade
HLhelen lambert
helen lambert
We investigated sociocultural and economic drivers of human antimicrobial use (AMU) in Thailand through ethnographic research, interviews, focus groups and a cross-sectional survey. This community-based study generated findings clustered around three key themes: treatment-seeking practices, medicine use, and interpretation of biomedical constructs. Participants sought care from public health facilities for chronic conditions, but medicines from the private sector were considered more powerful and were preferred for acute complaints. Many antibiotics were unrecognised as such by consumers due to the practice at private healthcare facilities of dispensing repackaged medicines without identifying labels. This unseen use of antibiotics is probably driven by economic drivers including market competition in the private sector, policy implementation drivers whereby rational drug use policies mainly target the public sector, behavioural drivers relating to treatment seeking-practices, and sociocultural drivers that influenced participants' understanding of medical terms and concepts. Participants regarded antibiotics as reducing inflammation and were uncertain about the distinctions between anti-inflammatories, antibiotics, and pain relievers. Antimicrobial Resistance (AMR) was understood as a form of drug tolerance to be remedied by changing the medicine. Community surveys may not provide accurate estimates of AMU where people are unable to distinguish antibiotics reliably from other medicines.

21 September 2021 in Exploratory Research in Clinical and Social Pharmacy
Verified
Journal Article
Open access
NAN. Alhusein
N. Alhusein
JSJennifer Scott
Jennifer Scott
JNJoanne Neale
Joanne Neale
ACAngel Marie Chater
Angel Marie Chater
HFHannah Family
Hannah Family
The absence of menstruation is common in women who use drugs. This can give a belief that conception is unlikely. When stabilised on Opioid Substitution Treatment (OST), fertility often returns, initially without realisation as ovulation precedes menstruation. This leaves women vulnerable to unplanned pregnancies. Community pharmacists (CPs) are frequently in contact with this patient group through the Supervised Consumption of OST service. This provides a timely opportunity to provide reproductive health (RH) advice. The aim of this study was to investigate pharmacists' views on providing a RH service to women receiving OST. Twenty semi-structured interviews based on the Capability-Opportunity-Motivation to Behaviour (COM-B) model and the Theoretical Domains Framework (TDF) were conducted between 2016 and 2017. Data analysis involved deductive coding using the TDF domains. The TDF domains were mapped onto the elements of the COM-B and used in the second step to create the framework and chart the data. The third step involved re-reading and clustering the codes, and inductive themes were generated to explain the data in depth. Nine of the 14 TDF domains, mapped into five elements of the COM-B, were identified. Five inductive themes were generated: 1) The pharmacists' experience and knowledge of reproductive health (RH) needs of women receiving OST, 2) The pharmacists' approach to providing advice, 3) The pharmacists' perception of the relationship with women receiving OST, 4) Social influences, and 5) Environmental factors. Community pharmacists feared causing offense to women receiving OST and described requiring cues as to when the service was needed. Pharmacists' highlighted a power imbalance in the relationship with women receiving OST. This could influence how receptive this patient group would be to pharmacy RH interventions. CPs' concerns of providing RH service could hinder a proactive service provision. Supporting good rapport and providing a structured consultation would increase the accessibility of such a service.

11 July 2025 in Frontiers in Veterinary Science
Verified
Journal Article
Open access
PDF file
NANour Alhusein
Nour Alhusein
BCBoonrat Chantong
Boonrat Chantong
SSSarin Suwanpakdee
Sarin Suwanpakdee
AWAnuwat Wiratsudakul
Anuwat Wiratsudakul
VGVirginia C. Gould
Virginia C. Gould
KRKristen K Reyher
Kristen K Reyher
Introduction: Recent years have shown substantial growth both in the scale and the spread of freshwater aquaculture in Thailand, raising concerns about potential widespread unsustainable use of antimicrobials.Methods: This mixed-methods study used surveys and qualitative interviews to examine conditions of freshwater aquaculture farming in central Thailand in relation to animal health, disease management and patterns of antimicrobial use.Results: Freshwater aquaculture in this area of Thailand was largely a domestic venture operated as a source of additional household income to increase financial security. Aquaculture was often integrated with other types of farming; initial outlay was reduced by repurposing unused crops, food, or animal manure (e.g. chicken droppings and pig dung) to fertilise aquaculture ponds. Among farmers representing twenty farms who were surveyed during 2019, only six farmers representing six farms said they used antimicrobials. These included oxytetracycline, enrofloxacin, norfloxacin, ciprofloxacin and sulphonamides. Farmers doubted the benefits of using antimicrobials to treat aquatic animals; some believed antimicrobials stunted growth. The high cost of medicines and prohibitive regulations also discouraged antimicrobial use. Farmers linked disease occurrence to changes in the weather, the emergence of new diseases and variable water quality. They relied on farm management practices to maintain the health of their aquatic animals, using lime and salt to maintain and improve water quality and pH and to disinfect aquaculture pools. Farmers also reported obtaining juvenile fish and shrimp selectively from farms known to produce healthy stock. Specialised veterinary services for aquatic farming were rare, so farmers relied on their own experimentation with medicines, peer advice and recommendations of shopkeepers who sold both aquatic feed and medicines.Conclusion: This study unexpectedly reveals limited use of antimicrobials linked to socio-economic and ecological features of small-scale family aquaculture farms.